Literature DB >> 11097052

[2,1-c][1,4]benzodiazepine (PBD)-distamycin hybrid inhibits DNA binding to transcription factor Sp1.

P G Baraldi1, B Cacciari, A Guiotto, R Romagnoli, G Spalluto, A Leoni, N Bianchi, G Feriotto, C Rutigliano, C Mischiati, R Gambari.   

Abstract

We designed and synthesized the hybrid 6, prepared combining the minor groove binders distamycin A and pyrrolo [2,1-c][1,4] benzodiazepine (PBD) 4, related to the natural occurring anthramycin (2) and DC-81 (3). In this paper, the effects of the compound 6 on molecular interactions between DNA and transcription factor Sp1 were studied. The results obtained demonstrate that PBD-distamycin hybrid is a powerful inhibitor of Sp1/DNA interactions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11097052     DOI: 10.1080/15257770008033045

Source DB:  PubMed          Journal:  Nucleosides Nucleotides Nucleic Acids        ISSN: 1525-7770            Impact factor:   1.381


  2 in total

Review 1.  Biosynthesis, synthesis, and biological activities of pyrrolobenzodiazepines.

Authors:  Barbara Gerratana
Journal:  Med Res Rev       Date:  2010-06-13       Impact factor: 12.944

Review 2.  From Anthramycin to Pyrrolobenzodiazepine (PBD)-Containing Antibody-Drug Conjugates (ADCs).

Authors:  Julia Mantaj; Paul J M Jackson; Khondaker M Rahman; David E Thurston
Journal:  Angew Chem Int Ed Engl       Date:  2016-11-15       Impact factor: 15.336

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.